BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21501577)

  • 21. gp130RB13-6-positive neural progenitor cells are susceptible to the oncogenic effect of ethylnitrosourea in pre-natal rat brain.
    Blass-Kampmann S; Bilzer T; Rajewsky MF
    Neuropathol Appl Neurobiol; 1998 Feb; 24(1):9-20. PubMed ID: 9549724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison between stem cells from the adult human brain and from brain tumors.
    Varghese M; Olstorn H; Sandberg C; Vik-Mo EO; Noordhuis P; Nistér M; Berg-Johnsen J; Moe MC; Langmoen IA
    Neurosurgery; 2008 Dec; 63(6):1022-33; discussion 1033-4. PubMed ID: 19057315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that nucleocytoplasmic Olig2 translocation mediates brain-injury-induced differentiation of glial precursors to astrocytes.
    Magnus T; Coksaygan T; Korn T; Xue H; Arumugam TV; Mughal MR; Eckley DM; Tang SC; Detolla L; Rao MS; Cassiani-Ingoni R; Mattson MP
    J Neurosci Res; 2007 Aug; 85(10):2126-37. PubMed ID: 17510983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of adult neural stem cells and their relation to brain tumors.
    Jackson EL; Alvarez-Buylla A
    Cells Tissues Organs; 2008; 188(1-2):212-24. PubMed ID: 18223308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
    Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
    Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas.
    Plate KH; Breier G; Farrell CL; Risau W
    Lab Invest; 1992 Oct; 67(4):529-34. PubMed ID: 1434531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors.
    Shoshan Y; Nishiyama A; Chang A; Mörk S; Barnett GH; Cowell JK; Trapp BD; Staugaitis SM
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10361-6. PubMed ID: 10468613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glial progenitors as targets for transformation in glioma.
    Ilkhanizadeh S; Lau J; Huang M; Foster DJ; Wong R; Frantz A; Wang S; Weiss WA; Persson AI
    Adv Cancer Res; 2014; 121():1-65. PubMed ID: 24889528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progenitor cells and glioma formation.
    Holland EC
    Curr Opin Neurol; 2001 Dec; 14(6):683-8. PubMed ID: 11723374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interface between glial progenitors and gliomas.
    Canoll P; Goldman JE
    Acta Neuropathol; 2008 Nov; 116(5):465-77. PubMed ID: 18784926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor initiating cells in malignant gliomas: biology and implications for therapy.
    Hadjipanayis CG; Van Meir EG
    J Mol Med (Berl); 2009 Apr; 87(4):363-74. PubMed ID: 19189072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant gliomas: perverting glutamate and ion homeostasis for selective advantage.
    Sontheimer H
    Trends Neurosci; 2003 Oct; 26(10):543-9. PubMed ID: 14522147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gliomas: a reflection of temporal gliogenic principles.
    Sojka C; Sloan SA
    Commun Biol; 2024 Feb; 7(1):156. PubMed ID: 38321118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rediscovering Potential Molecular Targets for Glioma Therapy Through the Analysis of the Cell of Origin, Microenvironment and Metabolism.
    Guo X; Wang T; Huang G; Li R; Da Costa C; Li H; Lv S; Li N
    Curr Cancer Drug Targets; 2021; 21(7):558-574. PubMed ID: 33949933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glioma Cell and Astrocyte Co-cultures As a Model to Study Tumor-Tissue Interactions: A Review of Methods.
    Chekhonin IV; Chistiakov DA; Grinenko NF; Gurina OI
    Cell Mol Neurobiol; 2018 Aug; 38(6):1179-1195. PubMed ID: 29744691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gliomas "Dope Up" for Growth.
    Paolella BR; Stiles CD
    Cancer Cell; 2016 Jun; 29(6):778-780. PubMed ID: 27300432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASYMMETRIC CELL DIVISION: IMPLICATIONS FOR GLIOMA DEVELOPMENT AND TREATMENT.
    Lewis KM; Petritsch C
    Transl Neurosci; 2013 Dec; 4(4):484-503. PubMed ID: 25530875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defined human cellular systems in the study of glioma development.
    Pieper RO
    Front Biosci; 2003 Jan; 8():s19-27. PubMed ID: 12456369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain stem cells as the cell of origin in glioma.
    Modrek AS; Bayin NS; Placantonakis DG
    World J Stem Cells; 2014 Jan; 6(1):43-52. PubMed ID: 24567787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Microenvironment in Gliomas: Phenotypic Expressions.
    Schiffer D; Annovazzi L; Mazzucco M; Mellai M
    Cancers (Basel); 2015 Dec; 7(4):2352-9. PubMed ID: 26633514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.